Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Urovant, Sunovion Ink Distribution Pact for OAB Med Vibegron; Both Sumitomo Dainippon Units
June 22, 2020
- Pfizer Launches Celecox Authorized Generic, Its 1st AG
June 22, 2020
- Crysvita Approved for Tumor-Induced Osteomalacia in US: Kyowa Kirin/Ultragenyx
June 22, 2020
- Keytruda Logs 64% Growth, Tops FY2019 Drug Ranking: Jiho Tally
June 19, 2020
- 5 Authorized Generics Hit Japan Market on June 19
June 19, 2020
- Ono President Confident of Validity of Company’s Argument on Opdivo Royalties
June 19, 2020
- AZ Recalls Omepral Injection in Japan due to Flaws in Environmental Monitoring Data
June 19, 2020
- NanoCarrier’s NC-6004 Hits Goal in Keytruda Combo for Head and Neck Cancer
June 19, 2020
- Lilly’s Ultra-Fast Acting Insulin Lyumjev Now Available in Japan
June 18, 2020
- Kyowa Kirin Commits Up to US$10 Million in 4BIO Venture Fund, Its 1st VC Investment
June 18, 2020
- Takeda Out-Licenses 7 Psych Programs to Neurocrine
June 18, 2020
- Canada OKs Sunovion’s Apomorphine Sublingual Film for Parkinson’s
June 17, 2020
- 10 Foreign Makers in Japan Grow Above Market with 5.5% Sales Rise in 2019
June 17, 2020
- Distributors See 800 Item Shortages as Good Guesstimate as They Share Off-Year Survey Concerns with Chuikyo Wholesaler Rep
June 17, 2020
- Astellas Relaxes Commuting Rate Limit to 50% at HQ as COVID-19 Situation Improves
June 17, 2020
- Oncolys Inks US$300 Million-Plus Pact for OBP-601; Potential for Neurodegenerative Diseases Eyed
June 16, 2020
- Meiji/Solasia Plan Japan NDA for PTCL Med in First Half of 2021
June 16, 2020
- Taiho Files Aloxi for Pediatric Use
June 16, 2020
- Poteligeo Now Available in Germany: Kyowa Kirin
June 16, 2020
- Mitsubishi Tanabe Launches PIII Dersimelagon Study for Rare Protoporphyria, Targeting US Filing in FY2021
June 16, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…